Alkermes Pauses To Recognize National Ovarian Cancer Awareness Month
Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary
Alkermes recognizes Ovarian Cancer Awareness Month
Positive
- None.
Negative
- None.
NORTHAMPTON, MA / ACCESSWIRE / September 21, 2023 / Alkermes
September is Ovarian Cancer Awareness Month. We stand in solidarity with patients, caregivers and family members whose lives have been impacted by Ovarian Cancer. Our oncology team is dedicated to advancing research and developing potential new treatment options for those affected by this disease.
View additional multimedia and more ESG storytelling from Alkermes on 3blmedia.com.
Contact Info:
Spokesperson: Alkermes
Website: https://www.3blmedia.com/profiles/alkermes
Email: info@3blmedia.com
SOURCE: Alkermes
View source version on accesswire.com:
https://www.accesswire.com/786392/alkermes-pauses-to-recognize-national-ovarian-cancer-awareness-month
Alkermes Inc. plc
NASDAQ:ALKS
ALKS Rankings
ALKS Latest News
ALKS Stock Data
4.21B
158.79M
1.25%
108.01%
8.58%
Pharmaceutical Preparation Manufacturing
Manufacturing
United States of America
DUBLIN 4
About ALKS
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.